Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial-Reference-Cited by-同舟云学术

Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial

Published:2021-07 Issue:10295 Volume:398 Page:131-142
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sweeney Christopher,Bracarda Sergio,Sternberg Cora N,Chi Kim N,Olmos David,Sandhu Shahneen,Massard Christophe,Matsubara Nobuaki,Alekseev Boris,Parnis Francis,Atduev Vagif,Buchschacher Gary L,Gafanov Rustem,Corrales Luis,Borre Michael,Stroyakovskiy Daniil,Alves Gustavo Vasconcelos,Bournakis Evangelos,Puente Javier,Harle-Yge Marie-Laurence,Gallo Jorge,Chen Geng,Hanover Justin,Wongchenko Matthew J,Garcia Josep,de Bono Johann S

Funder

F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015

2. Metastatic prostate cancer;Sartor;N Engl J Med,2018

3. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology;Nuhn;Eur Urol,2019

4. Clinical implications of PTEN loss in prostate cancer;Jamaspishvili;Nat Rev Urol,2018

5. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis;European Journal of Pharmacology;2024-11

2. Environmental explanation of prostate cancer progression based on the comprehensive analysis of polychlorinated biphenyls;Science of The Total Environment;2024-10

3. Nature and nurture: addressable causes of disparities in prostate cancer care and survivorship in Black men;Expert Review of Anticancer Therapy;2024-08-30

4. Editorial: Molecular mechanisms in lethal states of prostate cancer;Frontiers in Oncology;2024-08-20

5. Molekulare Tumorboards in der Uroonkologie – Prostatakarzinom;Die Urologie;2024-08-06